Proactive
INNOVATION
in Fetal-Maternal Healthcare
NEO LIFE
We do cool things for the greater good
NEO-LIFE is a collaborative data sharing framework that fosters the seamless exchange of knowledge and best practices between academia, industry, and public fetal-maternal healthcare, ensuring rapid translation of research into clinical applications and policy advancements.
It brings together, Greek, Estonian and Dutch Academic, National Healthcare and Deep Tech StartUp Partners whose mission is to advance the next generation of precision fetal-maternal health solutions. We integrate state-of-the-art non-invasive omics, advanced imaging, and responsible AI to deliver deeper, earlier, and safer insights into fetal–maternal health. Our mission is to empower clinicians, support
We do this by establishing a sustainable, cross-sectoral knowledge transfer ecosystem with a particular emphasis on creating harmonized, shared resources. The NEO-LIFE initiative facilitates the mobility of the next generation of cross-disciplinary experts, facilitating their movement and collaboration across sectors to drive impactful, real-world solutions.
Research Objectives
We harness the power of digitalization, AI-driven data analytics, and federated data infrastructures to transform reproductive medicine and in specific the domain of non-invasive prediction of adverse obstetric outcomes.
We advance maternal-fetal medicine by introducing precision-driven, AI-enhanced reproductive health technologies that improve outcomes and accessibility.
We pioneer a sustainable, lifecycle-based approach to AI-powered reproductive medicine, ensuring that biomedical innovations remain ethical, scalable, and regulatory-compliant while continuously improving healthcare outcomes.
Work Packages
Work package 1 focuses on establishing a robust staff exchange methodology to facilitate knowledge transfer and collaboration among partner institutions.
Work package 2 focuses on developing an automated annotation system using augmented reality and artificial intelligence to enhance diagnostic accuracy and efficiency.
Work package 3 focuses on developing integrative genomic and radiomic tools for placental pathology analysis, enabling more precise diagnostic capabilities.
Work package 4 focuses on designing the IT infrastructure and data housing solutions for the NEO-LIFE platform, including the deployment of AI models for enhanced data processing and analysis.
Work package 5 focuses on developing standardized procedures and methods for federated data sharing to ensure secure and efficient exchange of information among collaborating institutions.
Work package 6 focuses on dissemination, communication, and exploitation activities to maximize the impact of the project outcomes and ensure effective knowledge transfer to relevant stakeholders.
Work package 7 focuses on project management activities, ensuring the smooth execution and coordination of all project components.
Progress
Alexandra Hospital
The Department of Medical Genetics at G.N.A. Alexandra (MGLA)is the only public health unit providing medical and clinical genetic services within the Greek National Health System.
Celvia
CELVIA was established in 2009 in Tartu (Estonia), forming the Research & Technology Organization (RTO).
Genomedai
Consulting in the field of genetics and reproductive medicine, as well as research.
Quantorio
Quantorio is a deep-tech research startup, founded in Athens-Greece, focusing on software development, artificial intelligence and machine learning applications.
University of Maastricht
Maastricht University Medical Center is a major player in clinical genetics in the Netherlands.
University of Peloponnese
University of Peloponnese (UoP) is a modern and multi-disciplinary academic institution with a strong regional, national, and international presence.
Meet Our Team
Alexandra Hospital is the coordinator of NEO-LIFE, leading the clinical and translational aspects of the project.
NEO-LIFE research project is comprised of a list of top in their fields partners."